Leadership Team

The Leadership Team at OcuTerra Therapeutics is responsible for guiding the company's strategic direction and overseeing the development of OTT166. Comprised of key executives including the Chief Medical Officer, VP of Clinical & Medical Affairs, and CFO, this team drives clinical innovation, ensures regulatory compliance, and manages financial sustainability, all while focusing on the advancement of revolutionary treatments for diabetic eye disease.